PCR64 Patient Satisfaction With 6-Monthly Versus 3-Monthly Paliperidone Palmitate Long-Acting Injectable for Schizophrenia Treatment: Results From a Phase-3, Randomised, Noninferiority Study
Abstract
Authors
R Milz P Desai P Sanga H Rozjabek A Keenan S Wang JM Pelayo-Terán S Gopal